BrightSpring Health Services, Inc. Common Stock(BTSG)Earnings, Financials & Key RatiosBrightSpring Health Services, Inc. Common Stock (BTSG) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company has successfully reduced its debt-to-equity ratio to 0.13, the high forward P/E of 40.83 and thin 3.4% operating margin suggest that significant operational execution risk remains.
BrightSpring Health Services, Inc. Common Stock (BTSG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
BrightSpring Health Services, Inc. Common Stock (BTSG) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 1, 2026 | $0.39vs $0.29+34.5% | $3.6Bvs $3.4B+6.6% |
| Q1 2026 | Feb 27, 2026 | $0.33vs $0.34-2.9% | $3.6Bvs $3.4B+5.0% |
| Q4 2025 | Oct 31, 2025 | $0.30vs $0.26+13.9% | $3.3Bvs $3.2B+5.3% |
| Q3 2025 | Aug 1, 2025 | $0.22vs $0.19+15.8% | $3.1Bvs $3.2B-0.6% |
Recent stock market news and headlines for BrightSpring Health Services, Inc. Common Stock (BTSG)
Does BrightSpring Health Services, Inc. (BTSG) have what it takes to be a top stock pick for momentum investors? Let's find out.
BTSG's specialty, infusion and provider services momentum support growth, but IRA pressures and integration risks may weigh on margins.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Explore how portfolio size and sector exposure differ between these two small-cap ETFs, each offering unique advantages for investors.
If you are looking for stocks that are well positioned to maintain their recent uptrend, BrightSpring Health Services, Inc. (BTSG) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Key metrics vs top competitors for BrightSpring Health Services, Inc. Common Stock (BTSG)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $70.17 | $13.55B | 80.66 | 14.59% | 1.48% | 10.78% | — | |
| $10.90 | $4.23B | 545.00 | 13.85% | 1.55% | 1.56% | — | |
| $31.92 | $2.94B | -2.63 | 5.04% | -32.84% | -40.92% | — | |
| $170.87 | $9.98B | 29.26 | 18.72% | 6.89% | 16.61% | — | |
| $105.97 | $1.98B | 20.34 | 23.21% | 6.89% | 9.34% | — | |
| $13.22 | $427.44M | -4.51 | -21.56% | -9.84% | -27.1% | — |
BrightSpring Health Services, Inc. Common Stock (BTSG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
BrightSpring Health Services, Inc. Common Stock (BTSG) SEC filings — annual & quarterly reports (10-K, 10-Q)
Mar 31, 2026·SEC
Mar 4, 2026·SEC
Feb 27, 2026·SEC
Get notified when BTSG posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
BrightSpring Health Services, Inc. Common Stock (BTSG) stock FAQ — growth, dividends, profitability & financials explained
BrightSpring Health Services, Inc. Common Stock (BTSG) reported $13.65B in revenue for fiscal year 2025. This represents a 202% increase from $4.53B in 2019.
BrightSpring Health Services, Inc. Common Stock (BTSG) grew revenue by 14.6% over the past year. This is steady growth.
Yes, BrightSpring Health Services, Inc. Common Stock (BTSG) is profitable, generating $309.9M in net income for fiscal year 2025 (1.5% net margin).
BrightSpring Health Services, Inc. Common Stock (BTSG) has a return on equity (ROE) of 10.8%. This is reasonable for most industries.
BrightSpring Health Services, Inc. Common Stock (BTSG) generated $507.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
